Adenine-Based Acyclic Nucleotides as Novel P2X3 Receptor Ligands-Reference-Cited by-同舟云学术

Adenine-Based Acyclic Nucleotides as Novel P2X3 Receptor Ligands

Published:2009-07-16 Issue:15 Volume:52 Page:4596-4603
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Volpini Rosaria¹,Mishra Ram Chandra¹,Kachare Dhuldeo D.¹,Ben Diego Dal¹,Lambertucci Catia¹,Antonini Ippolito¹,Vittori Sauro¹,Marucci Gabriella¹,Sokolova Elena²,Nistri Andrea²,Cristalli Gloria¹

Affiliation:

1. Department of Chemical Sciences, University of Camerino, Via S. Agostino 1, 62032 Camerino, Italy

2. Sector of Neurobiology and Italian Institute of Technology Unit, International School for Advanced Studies (SISSA), Via Beirut 2/4, 34014 Trieste, Italy

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm900131v

Reference32 articles.

1. Purinergic signalling and disorders of the central nervous system

2. P2X purinoceptors and sensory transmission

3. Pharmacological properties of P2X3 -receptors present in neurones of the rat dorsal root ganglia

4. P2X receptors as cell-surface ATP sensors in health and disease

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. P2X3 Receptor Ligands: Structural Features and Potential Therapeutic Applications;Frontiers in Pharmacology;2021-04-13

2. Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications;Expert Opinion on Therapeutic Patents;2019-11-20

3. Synthesis and anti-HSV activity of tricyclic penciclovir and hydroxybutylguanine derivatives;Bioorganic & Medicinal Chemistry;2019-03

4. Investigation on 2′,3′-O-Substituted ATP Derivatives and Analogs as Novel P2X3 Receptor Antagonists;ACS Medicinal Chemistry Letters;2018-12-26

5. 2′,3′-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents;Purinergic Signalling;2016-10-18